CYCLERION THERAPEUTICS, INC. (KRSA) Capital expenditures 2018–2022
CYCLERION THERAPEUTICS, INC. (KRSA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2022 · since FY2018: $3.4M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $0 | -100.0% |
| FY2021 | $7,000 | -99.5% |
| FY2020 | $1.5M | -77.9% |
| FY2019 | $6.9M | +100.3% |
| FY2018 | $3.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice